Predominant role of peripheral catecholamines in the stress-induced modulation of CYP1A2 inducibility by benzo(α)pyrene

Basic and Clinical Pharmacology and Toxicology

Volumn 102, Issue 1, 2008, Pages 35-44

  Konstandi, Maria ^a   Lang, Matti A ^b   Kostakis, Dimitris ^a   Johnson, Elizabeth O ^a   Marselos, Marios ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROPHENOL HYDROXYLASE; 7 METHOXYRESORUFIN O DEALKYLASE; ALPHA 2 ADRENERGIC RECEPTOR; BENZO[A]PYRENE; CATECHOLAMINE; CYTOCHROME P450 1A2; CYTOCHROME P450 2B1; CYTOCHROME P450 2B2; OXYGENASE; PENTOXYRESORUFIN DEALKYLASE; UNCLASSIFIED DRUG; UNCLASSIFIED ENZYME;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYP1A2 GENE; ENZYME ACTIVITY; GENE; GENE EXPRESSION; LIVER; MALE; NONHUMAN; NORADRENERGIC SYSTEM; POLLUTANT; PRIORITY JOURNAL; PROTEIN DEPLETION; STRESS; UPREGULATION;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; BENZO(A)PYRENE; CATECHOLAMINES; CYTOCHROME P-450 CYP1A2; DEXMEDETOMIDINE; DRUG THERAPY, COMBINATION; ENVIRONMENTAL POLLUTANTS; ENZYME INDUCTION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GUANETHIDINE; IMIDAZOLES; INJECTIONS, INTRAPERITONEAL; MALE; MICROSOMES, LIVER; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-2; RESERPINE; RESTRAINT, PHYSICAL; STRESS;

RATTUS; RATTUS NORVEGICUS;

EID: 37349069977     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2007.00154.x     Document Type: Article

References (54)

1. Yamazoe Y, Shimada M, Murayama N, Kato R. Suppression of levels of phenobarbital-inducible rat liver cytochrome P-450 by pituitary hormone. J Biol Chem 1987 262 : 7423 28.
2. Gelboin HV. Cytochrome P450 and monoclonal antibodies. Pharmacol Rev 1993 45 : 413 53.
3. Waxman DJ. Interactions of hepatic cytochromes P-450 with steroid hormones. Biochem Pharmacol 1988 37 : 71 84.
4. Pelkonen O, Nebert DW. Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. Pharmacol Rev 1982 34 : 189 222.
5. Boelsterli UA, Lanzotti A, Goldlin C, Oertle M. Identification of cytochrome P-450IIB1 as a cocaine-bioactivating isoform in rat hepatic microsomes and in cultured rat hepatocytes. Drug Metab Dispos 1992 20 : 96 101.
6. Montero R, Serrano L, Davila VM, Ito A, Plancarte A. Infection of rats with Taenia taeniformis metacestodes increases hepatic CYP450, induces the activity of CYP1A1, CYP2B1 and COH isoforms and increases the genotoxicity of the precarcinogens benzo[α]pyrene, cyclophosphamide and aflatoxin B1. Mutagenesis 2003 18 : 211 16.
7. Nebert DW, Roe AL, Dieter MZ, Solis WA, Yang Y, Dalton TP. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem Pharmacol 2000 59 : 65 85.
8. Cherng SH, Lin P, Yang JL, Hsu SL, Lee H. Benzo[g,h,I]perylene synergistically transactivates benzo[a]pyrene-induced CYP1A1gene expression by Aryl hydrocarbon receptor pathway. Toxicol Appl Pharmacol 2001 170 : 63 8.
9. Reinke LA, Moyer MJ. p-Nitrophenol hydroxylation. A microsomal oxidation which is highly inducible by ethanol. Drug Metab Dispos 1985 13 : 548 52.
10. Gonzalez FJ. Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1. Mutat Res 2005 569 : 101 10.
11. Konstandi M, Marselos M, Camus-Radon AM, Johnson E, Lang MA. The role of stress in the regulation of drug metabolizing enzymes in mice. Eur J Drug Metab Pharmacokinet 1998a 23 : 483 90.
12. 2-adrenoceptor involvement in B(α)P induction processes of drug-metabolizing enzymes: the effect of stress. Eur J Drug Metab Pharmacokinet 1998b 23 : 491 95.
13. Konstandi M, Johnson E, Lang MA, Camus-Radon AM, Marselos M. Stress modulates the enzymatic inducibility by benzo[α]pyrene in the rat liver. Pharmacol Res 2000 42 : 205 11.
14. Konstandi M, Johnson EO, Marselos M, Kostakis D, Fotopoulos A, Lang MA. Stress-mediated modulation of B(α)P-induced hepatic CYP1A1: role of catecholamines. Chem Biol Interact 2004 147 : 65 77.
15. Harbuz MS, Lightman SL. Responses of hypothalamic and pituitary mRNA to physical and psychological stress in the rat. J Endocrinol 1989 122 : 705 11.
16. De Paula Brotto MA. Temporal effects of stress by immobilization and sensitivity of the isolated rat pacemaker to isoproterenol: roles of corticosterone, neuronal uptake, and β-adrenergic homogeneity. J Pharmacol Exp Ther 2003 306 : 1152 58.
17. Johnson EO, Kamilaris TC, Chrousos G, Gold PW. Mechanisms of stress: a dynamic overview of hormonal and behavioral homeostasis. Neurosci Biobehav Rev 1992 16 : 115 30.
18. Calogero AE. Neurotransmitter regulation of the hypothalamic corticotropin-releasing hormone neuron. Ann N Y Acad Sci 1995 771 : 31 40.
19. Chrousos GP. The HPA axis and the stress response. Endocr Res 2000 26 : 513 14.
20. Plotsky PM. Facilitation of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation after activation of catecholaminergic pathways or central norepinephrine injection. Endocrinology 1987 121 : 924 30.
21. Cunningham ET Jr., Sawchenko PE. Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J Comp Neurol 1988 274 : 60 76.
22. Finn DP, Hudson AL, Kinoshita H et al. Imidazoline2 (I2) receptor-and alpha2-adrenoceptor-mediated modulation of hypothalamic-pituitary-adrenal axis activity in control and acute restraint stressed rats. J Psychopharmacol 2004 18 : 47 53.
23. Hudson AL, Robinson ES, Lalies MD, Tyacke RJ, Jackson HC, Nutt DJ. In vitro and in vivo approaches to the characterization of the alpha2-adrenoceptor. J Auton Pharmacol 1999 19 : 311 20.
24. Kawahara H, Kawahara Y, Westerink BH. The role of afferents to the locus coeruleus in the handling stress-induced increase in the release of noradrenaline in the medial prefrontal cortex: a dual-probe microdialysis study in the rat brain. Eur J Pharmacol 2000 387 : 279 86.
25. Glavin GB. Stress and noradrenaline: a review. Neurosci Biobehav Rev 1985 9 : 233 43.
26. Anisman H, Kokkinidis L, Sklar LS. Neurochemical consequences of stress. Contributions of adaptive processes. In : Burchaeld S (ed.). STRESS: Psychological and Physiological Interactions. Hemispheke Publishing Co., New York, 1985 67 98.
27. Virtanen R. Pharmaceutical profiles of metedomidine and its antagonist, atipamezole. Acta Vet Scand 1989 85 : 29 37.
28. Nebert DW. The Ah locus: genetic differences in toxicity, cancer, mutation, and birth defects. CRC Crit Rev Toxicol 1989 20 : 153 74.
29. Ioannides C, Parke DV. The cytochrome P450 I gene family of microsomal hemoproteins and their role in the metabolic activation of chemicals. Drug Metab Rev 1990 22 : 1 85.
30. Honkakoski P, Kojo A, Lang MA. Regulation of the mouse liver cytochrome P450 2B subfamily by sex hormones and phenobarbital. Biochem J 1992 285 : 979 83.
31. Chen GF, Ronis MJ, Ingelman-Sundberg M, Badger TM. Hormonal regulation of microsomal cytochrome P4502E1 and P450 reductase in rat liver and kidney. Xenobiotica 1999 29 : 437 51.
32. Woodcroft KJ, Hafner MS, Novak RF. Insulin signaling in the transcriptional and posttranscriptional regulation of CYP2E1 expression. Hepatology 2002 35 : 263 73.
33. Scheinin H, Scheinin M. Repetitive measurement of monoamine metabolite levels in cerebrospinal fluid of conscious rats: effects of reserpine and haloperidol. Eur J Pharmacol 1985 113 : 345 51.
34. Benarroch EE, Schmelzer JD, Ward KK, Nelson DK, Low PA. Noradrenergic and neuropeptide mechanisms in guanethidine-sympathectomized rats. Am J Physiol 1990 2 : R371 5.
35. Scheinin H, Aantaa R, Anttila M, Hakola P, Helminen A, Karhuvaara S. Reversal of the sedative and sympatholytic effects of dexmedetomidine with a specific alpha2-adrenoceptor antagonist atipamezole: a pharmacodynamic and kinetic study in healthy volunteers. Anesthisiology 1998 89 : 574 84.
36. Mefford IN. Application of high performance chromatography with electrochemical detection to neurochemical analysis: measurement of catecholamines, serotonin and metabolites in rat brain. J Neurosci Methods 1981 3 : 207 24.
37. Stephanou P, Konstandi M, Pappas P, Marselos M. Alterations in central monoaminergic neurotransmission induced by polycyclic aromatic hydrocarbons in rats. Eur J Drug Metab Pharmacokinet 1998 23 : 475 81.
38. Sogawa K, Gotoh O, Kawajiri K, Harada T, Fujii-Kuriyama Y. Complete nucleotide sequence of a methylcholanthrene-inducible cytochrome P-450(P-450d) gene in the rat. J Biol Chem 1985 260 : 5026 32.
39. Lang MA, Gielen JE, Nebert DW. Genetic evidence for many unique liver microsomal P-450 mediated monoxygenase activities in heterogeneic stock mice. J Biol Chem 1981 256 : 12068 75.
40. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951 193 : 265 75.
41. Omura T, Sato R. The carbon monoxide-binding pigment of liver microsomes. II Solubilization, purification and properties. J Biol Chem 1964 239 : 2379 85.
42. Burke MD, Majer RT. Inherent specificities of purified cytochromes P-450 and P-448 toward biphenyl hydroxylation and ethoxyresorufin deethylation. Drug Metab Dispos 1975 3 : 245 53.
43. McManus ME, Felton JS, Knize MG et al. Activation of the food derived mutagen 2-amino-3-methyl-6-phenylimidazo(4,5,6)pyridine by rabbit and human liver microsomes and purified forms of cytochrome P-450. Carcinogenesis 1989 10 : 357 64.
44. Honkakoski P, Auriola S, Lang MA. Distinct induction profiles of three phenobarbital-responsive mouse liver cytochrome P450 isozymes. Biochem Pharmacol 1992 43 : 2121 28.
45. Burke MD, Thompson S, Weaver RJ, Wolf CR, Mayer RT. Cytochrome P450 specificities of alkoxyresorufin 0-dealkylation in human and rat liver. Biochem Pharmacol 1994 48 : 923 36.
46. Rodrigues AD, Prough RA. Induction of cytochromes P4501A1 and P4501A2 and measurement of catalytic activities. Methods Enzymol 1991 206 : 423 31.
47. Cawley GF, Zhang S, Kelley RW, Backes WL. Evidence supporting the interaction of CYP2B4 and CYP1A2 in microsomal preparations. Drug Metab Dispos 2001 29 : 1529 34.
48. Honkakoski P, Lang MA. Mouse liver phenobarbital-inducible P450 system: purification, characterization and differential inducibility of four cytochrome P450 isozymes from D2 mouse. Arch Biochem Biophys 1989 273 : 42 57.
49. Konstandi M, Kostakis D, Harkitis P et al. Benzo(alpha)pyrene-induced up-regulation of CYP1A2 gene expression: Role of adrenoceptor-linked signaling pathways. Life Sci 2006 79 : 331 41.
50. Sherratt AJ, Banet DE, Prough RA. Glucocorticoid regulation of polycyclic aromatic hydrocarbon induction of cytochrome P4501A1, glutathione S-transferases and NAD(P)H: quinone oxidoreductase in cultured fetal rat hepatocyte. Mol Pharmacol 1990 37 : 198 205.
51. Devaux A, Pesonen M, Monod G, Andersson T. Glucocorticoid-mediated potentiation of P450 induction in primary culture of rainbow trout hepatocytes. Biochem Pharmacol 1992 43 : 898 901.
52. Fujii-Kuriyama Y, Imataka H, Sogawa K, Yasumoto KI, Kikuchi Y. Regulation of CYP1A1 expression. FASEB J 1992 6 : 706 10.
53. Riley V. Psychoendocrine influences on immunocopetence and neoplasia. Science 1981 212 : 1100 9.
54. Fox BH. The role of psychological factors in cancer incidence and prognosis. Oncology (Huntingt) 1995 9 : 245 53.